MEDTRONIC HEART VALVES DIVISION EVOLUT FX DCS; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV
|
Back to Search Results |
|
Model Number D-EVOLUTFX-2329 |
Device Problems
Device Dislodged or Dislocated (2923); Patient Device Interaction Problem (4001)
|
Patient Problem
Hematoma (1884)
|
Event Date 04/11/2024 |
Event Type
Injury
|
Manufacturer Narrative
|
Continuation of d10: this is a system report.The section d information is for the primary device, which was in use with the following: product id: evolutfx-29, serial/lot #: (b)(6), ubd: 09-nov-2025, udi#: (b)(4).Other medical products in use during the event include: product id l-evolutfx-2329 (lot: 0012103491); product type: 0195-heart valves; select patient information cannot be included in regulatory report due to regional privacy regulations.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Event Description
|
Medtronic received information that during the implant of this transcatheter bioprosthetic valve, the valve was deployed without issue but was dislodged by the delivery catheter system (dcs) nose cone as it was being withdrawn from the left ventricle.The valve was snared up above the sinotubular junction (stj) and a second valve was implanted.A small hematoma was noted at the femoral site needed for the snare.The patient was reported to be stable.No additional adverse patient effects were reported.
|
|
Manufacturer Narrative
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Event Description
|
Additional information was received that the cause of the hematoma was difficult access.Manual pressure to the femoral site was provided for the hematoma.The valve was implanted into the native annulus.Prior to slowly withdrawing the delivery catheter system (dcs), the nose cone was centered within the frame inflow by slightly retracting the guidewire.
|
|
Search Alerts/Recalls
|
|
|